Zetia News
Most Popular Zetia Story
Why was the Niaspan vs. Zetia trial stopped?
Yes, folks, we have another cholesterol-drug trial mystery on our hands. A study comparing Abbott's Niaspan drug with Merck/Schering-Plough's Zetia was terminated by an independent steering... Read more...
Latest Headlines
- December 23, 2009
- November 25, 2009
- November 17, 2009
- November 10, 2009
- July 20, 2009
- July 10, 2009
- July 9, 2009
- November 17, 2008
- September 11, 2008
- May 29, 2008
- March 18, 2008
- March 14, 2008
- February 15, 2008
- January 23, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
